Evidence map›Paper›PMID 38250615›Full record

ArticleJournal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada2024

AMMI Canada Practice Point: Updated recommendations for treatment of adults with symptomatic COVID-19 in 2023-2024.

Jennifer M Grant, John Lam, Sohal V Goyal, Sylvain Lother, Sameer S Kassim, Stephen B Lee, Justin Chan, Gabriel Girouard, Lisa Barrett, Satchan Takaya and 4 more

Abstract read
In one paragraph

Article in Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jennifer M GrantDivisions of Medical Microbiology and Infectious Diseases, University of British Columbia, Vancouver, British Columbia, Canada.
John LamDivision of Infectious Diseases, Department of Medicine, University of California, Los Angeles, California, USA.
Sohal V GoyalDepartment of Family Medicine, McMaster University, Hamilton, Ontario, Canada.
Sylvain LotherSections of Infectious Diseases and Critical Care, University of Manitoba, Manitoba, Canada.
Sameer S KassimDepartment of Family Medicine, University of Manitoba, Manitoba, Canada.
Stephen B LeeDivision of Infectious Diseases, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Justin ChanDivision of Infectious Diseases and Immunology, Department of Medicine, NYU Grossman School of Medicine, New York, USA.
Gabriel GirouardCentre hospitalier universitaire Dr-Georges-L.-Dumont Vitalité Health Network, Moncton, New Brunswick, Canada.
Lisa BarrettInfectious Diseases NSHA, Dalhousie University, Halifax, Nova Scotia, Canada.
Satchan TakayaDivision of Infectious Diseases, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Jolanta PiszczekDepartment of Pharmacy, Royal Jubilee Hospital, Victoria, British Columbia, Canada.
Donald C VinhDivision of Infectious Diseases, Department of Medicine; Division of Medical Microbiology, Department of Laboratory Medicine, McGill University Health Centre, Montreal, Quebec, Canada.
Aidan R FindlaterDepartment of Medicine, McMaster University, Hamilton, Ontario, Canada.
Lynora SaxingerDivision of Infectious Diseases, University of Alberta, Edmonton, Alberta, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anti-inflammatory medicationsanti-microbial stewardshipanti-viral therapyCOVID-19gestion des antimicrobiensmédicaments anti-inflammatoiresrecommandations thérapeutiquesSARS-coV-2SRAS-CoV-2traitement antiviraltreatment recommendations

Identifiers

PMID38250615
PMCPMC10797770

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.